Literature DB >> 35048450

Structures of plasmepsin X from Plasmodium falciparum reveal a novel inactivation mechanism of the zymogen and molecular basis for binding of inhibitors in mature enzyme.

Pooja Kesari1, Anuradha Deshmukh1, Nikhil Pahelkar1, Abhishek B Suryawanshi1, Ishan Rathore1, Vandana Mishra1, John H Dupuis2, Huogen Xiao3, Alla Gustchina4, Jan Abendroth5,6, Mehdi Labaied5,6, Rickey Y Yada2, Alexander Wlodawer4, Thomas E Edwards5,6, Donald D Lorimer5,6, Prasenjit Bhaumik1.   

Abstract

Plasmodium falciparum plasmepsin X (PfPMX), involved in the invasion and egress of this deadliest malarial parasite, is essential for its survival and hence considered as an important drug target. We report the first crystal structure of PfPMX zymogen containing a novel fold of its prosegment. A unique twisted loop from the prosegment and arginine 244 from the mature enzyme is involved in zymogen inactivation; such mechanism, not previously reported, might be common for apicomplexan proteases similar to PfPMX. The maturation of PfPMX zymogen occurs through cleavage of its prosegment at multiple sites. Our data provide thorough insights into the mode of binding of a substrate and a potent inhibitor 49c to PfPMX. We present molecular details of inactivation, maturation, and inhibition of PfPMX that should aid in the development of potent inhibitors against pepsin-like aspartic proteases from apicomplexan parasites.
© 2022 The Protein Society.

Entities:  

Keywords:  49c inhibitor; P. falciparum; apicomplexan parasite; plasmepsin X; zymogen

Mesh:

Substances:

Year:  2022        PMID: 35048450      PMCID: PMC8927862          DOI: 10.1002/pro.4279

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  42 in total

1.  Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function.

Authors:  J Alfredo Bonilla; Tonya D Bonilla; Charles A Yowell; Hisashi Fujioka; John B Dame
Journal:  Mol Microbiol       Date:  2007-07       Impact factor: 3.501

2.  The origins of apicomplexan sequence innovation.

Authors:  James Wasmuth; Jennifer Daub; José Manuel Peregrín-Alvarez; Constance A M Finney; John Parkinson
Journal:  Genome Res       Date:  2009-04-10       Impact factor: 9.043

3.  Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases.

Authors:  Budhaditya Mukherjee; Francesca Tessaro; Juha Vahokoski; Inari Kursula; Jean-Baptiste Marq; Leonardo Scapozza; Dominique Soldati-Favre
Journal:  EMBO J       Date:  2018-03-08       Impact factor: 11.598

Review 4.  A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.

Authors:  William Checkley; A Clinton White; Devan Jaganath; Michael J Arrowood; Rachel M Chalmers; Xian-Ming Chen; Ronald Fayer; Jeffrey K Griffiths; Richard L Guerrant; Lizbeth Hedstrom; Christopher D Huston; Karen L Kotloff; Gagandeep Kang; Jan R Mead; Mark Miller; William A Petri; Jeffrey W Priest; David S Roos; Boris Striepen; R C Andrew Thompson; Honorine D Ward; Wesley A Van Voorhis; Lihua Xiao; Guan Zhu; Eric R Houpt
Journal:  Lancet Infect Dis       Date:  2014-09-29       Impact factor: 25.071

Review 5.  Invasion of red blood cells by malaria parasites.

Authors:  Alan F Cowman; Brendan S Crabb
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

6.  REFMAC5 for the refinement of macromolecular crystal structures.

Authors:  Garib N Murshudov; Pavol Skubák; Andrey A Lebedev; Navraj S Pannu; Roberto A Steiner; Robert A Nicholls; Martyn D Winn; Fei Long; Alexei A Vagin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

7.  phenix.mr_rosetta: molecular replacement and model rebuilding with Phenix and Rosetta.

Authors:  Thomas C Terwilliger; Frank Dimaio; Randy J Read; David Baker; Gábor Bunkóczi; Paul D Adams; Ralf W Grosse-Kunstleve; Pavel V Afonine; Nathaniel Echols
Journal:  J Struct Funct Genomics       Date:  2012-03-15

Review 8.  Drug Resistance in Toxoplasma gondii.

Authors:  Mahbobeh Montazeri; Saeed Mehrzadi; Mehdi Sharif; Shahabeddin Sarvi; Asal Tanzifi; Sargis A Aghayan; Ahmad Daryani
Journal:  Front Microbiol       Date:  2018-10-29       Impact factor: 5.640

9.  A druggable secretory protein maturase of Toxoplasma essential for invasion and egress.

Authors:  Sunil Kumar Dogga; Budhaditya Mukherjee; Damien Jacot; Tobias Kockmann; Luca Molino; Pierre-Mehdi Hammoudi; Ruben C Hartkoorn; Adrian B Hehl; Dominique Soldati-Favre
Journal:  Elife       Date:  2017-09-12       Impact factor: 8.140

10.  Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion.

Authors:  Armiyaw S Nasamu; Svetlana Glushakova; Ilaria Russo; Barbara Vaupel; Anna Oksman; Arthur S Kim; Daved H Fremont; Niraj Tolia; Josh R Beck; Marvin J Meyers; Jacquin C Niles; Joshua Zimmerberg; Daniel E Goldberg
Journal:  Science       Date:  2017-10-27       Impact factor: 47.728

View more
  2 in total

1.  Structures of plasmepsin X from Plasmodium falciparum reveal a novel inactivation mechanism of the zymogen and molecular basis for binding of inhibitors in mature enzyme.

Authors:  Pooja Kesari; Anuradha Deshmukh; Nikhil Pahelkar; Abhishek B Suryawanshi; Ishan Rathore; Vandana Mishra; John H Dupuis; Huogen Xiao; Alla Gustchina; Jan Abendroth; Mehdi Labaied; Rickey Y Yada; Alexander Wlodawer; Thomas E Edwards; Donald D Lorimer; Prasenjit Bhaumik
Journal:  Protein Sci       Date:  2022-02-05       Impact factor: 6.725

2.  Maturation and substrate processing topography of the Plasmodium falciparum invasion/egress protease plasmepsin X.

Authors:  Sumit Mukherjee; Suong Nguyen; Eashan Sharma; Daniel E Goldberg
Journal:  Nat Commun       Date:  2022-08-04       Impact factor: 17.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.